Funding for this research was provided by:
Academy of Finland
Sigrid Juséliuksen Säätiö
Finnish Cancer Foundation
Article History
Received: 22 December 2019
Revised: 19 May 2020
Accepted: 2 June 2020
First Online: 29 June 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable.
: All data presented in this review are publicly available.
: M.H. and S.J. own stocks of Faron Pharmaceuticals.
: The authors are supported by the Finnish Academy, the Finnish Cancer Foundation and Sigrid Juselius Foundation.